Oral corticosteroids for bronchiectasis (stable and acute exacerbations)

Citations of this article
Mendeley users who have this article in their library.
Get full text


Background: Inflammation plays a significant role in the pathophysiology of bronchiectasis. Two small studies have shown small benefits from inhaled corticosteroids and oral corticosteroids may be of benefit in bronchiectasis. Objectives: To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis. Search methods: The Cochrane Airways Group Specialised Register was searched and bibliographies of retrieved papers were checked. Searches are current as of May 2011. Selection criteria: Only randomised controlled trials were considered. Data collection and analysis: No trials met the inclusion criteria for the review. Main results: No randomised controlled trials were identified. Authors' conclusions: There are no randomised trials upon which to base recommendations about the use of oral corticosteroids in acute or stable bronchiectasis.




Lasserson, T. J., Holt, K., Milan, S. J., & Greenstone, M. (2001). Oral corticosteroids for bronchiectasis (stable and acute exacerbations). Cochrane Database of Systematic Reviews, 2011(6). https://doi.org/10.1002/14651858.CD002162

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free